Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

81.73
Delayed Data
As of 4:00pm ET
 -0.79 / -0.96%
Today’s Change
64.18
Today|||52-Week Range
86.72
+11.12%
Year-to-Date
Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle
Sep 16 / TheStreet.com - Paid Partner Content
Is Lilly Headed for the Valley?
Sep 13 / TheStreet.com - Paid Partner Content
Eli Lilly Still Looking for Lower Prices
Sep 15 / TheStreet.com - Paid Partner Content
Array's NDAs for Melanoma Combo Accepted for Review by FDA
Sep 13 / Zacks.com - Paid Partner Content
Lilly/Incyte's Baricitinib Meets Endpoint in Eczema Study
Sep 15 / Zacks.com - Paid Partner Content
AbbVie's RA Candidate Meets Primary Endpoint in Phase III
Sep 12 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Achillion Slumps on End of HCV Deal, Teva Gets a New CEO
Sep 15 / Zacks.com - Paid Partner Content
Lilly to Cut 3,500 Jobs to Invest in New Drugs and Growth
Sep 08 / Zacks.com - Paid Partner Content
4 Biotech Stocks That Show Promise on Sustainable Growth
Sep 14 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Lilly to Cut Jobs, Streamline Operations, NVS CEO to Step Down ...
Sep 08 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close82.52
Today’s open82.64
Day’s range81.55 - 82.84
Volume2,259,159
Average volume (3 months)3,593,090
Market cap$90.9B
Dividend yield2.54%
Data as of 4:00pm ET, 09/19/2017

Growth & Valuation

Earnings growth (last year)+14.16%
Earnings growth (this year)+18.25%
Earnings growth (next 5 years)+12.15%
Revenue growth (last year)+6.33%
P/E ratio35.4
Price/Sales3.68
Price/Book6.49

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories-0.67-1.29%
NVONovo Nordisk-0.02-0.04%
BMYBristol-Myers Squibb+0.23+0.37%
GSKGlaxoSmithKline-0.13-0.32%
Data as of 4:03pm ET, 09/19/2017

Financials

Next reporting dateOctober 24, 2017
EPS forecast (this quarter)$1.03
Annual revenue (last year)$21.2B
Annual profit (last year)$2.7B
Net profit margin12.90%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
David A. Ricks
Chief Financial Officer &
EVP-Global Services
Derica W. Rice
Corporate headquarters
Indianapolis, Indiana

Forecasts